POLE and gastric neoplasm: We found that a large fraction (92%) of TMB-extreme samples possessed at least one non-synonymous mutation in POLE in aggregated colorectal, endometrial, and stomach cancer samples, among which we detected a high recurrence of 2 known POLE driver mutations (P286R and V411L)7 (Supplementary Fig. 10).